An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Photo: Christophe Gateau/dpa (Photo by Christophe Gateau/picture alliance via Getty Images) ...

AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...

Researchers from the Department of Energy's Quantum Science Center (QSC) headquartered at Oak Ridge National Laboratory (ORNL) have achieved a significant milestone by demonstrating the first digital ...

Abstract: This study conducts a one-dimensional steady- state hydraulic analysis of CSU Creek using HEC-RAS to evaluate the effectiveness of a flood control structure proposed by the Department of ...

Researchers from Drexel University who discovered a versatile type of two-dimensional conductive nanomaterial, called a MXene, nearly a decade and a half ago, have now reported on a process for ...

Spinal deformities such as scoliosis and kyphosis are among the most serious complications of neurofibromatosis type 1 (NF1), a genetic disorder that affects about one in 3,000 people. These ...

1D-2D HEC-RAS Seminar - in Person - Hosted by Dory of Doral, March 17-21, 2025. This 5-day seminar includes lectures on unsteady flow modeling, 1D/2D flow theory, developing 1D/2D hydraulic models in ...

Liftoff occurred at 4:02 p.m. ET today (Nov. 4). When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Europe's Ariane 6 heavy-lift rocket took to the ...

Third-party model portfolios had $646 billion in assets under advisement as of March 31, 2025—an increase of 62% since Morningstar last surveyed for assets in June 2023, less than two years ago.

Forbes contributors publish independent expert analyses and insights. I write about the economics of AI. The AI boom has been defined by unprecedented innovation across nearly every sector. From ...